QR Kod

Effectiveness of sacubitril–valsartan in cancer patients with heart failure

Abstract Aims Current guidelines recommend sacubitril/valsartan for patients with heart failure and reduced left ventricular ejection fraction (LVEF), but there is lack of evidence of its efficacy and safety in cancer therapy‐related cardiac dysfunction (CTRCD). Our aim was to analyse the potential...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Ana Martín‐Garcia, Teresa López‐Fernández, Cristina Mitroi, Marinela Chaparro‐Muñoz, Pedro Moliner, Agustin C. Martin‐Garcia, Amparo Martinez‐Monzonis, Antonio Castro, Jose L. Lopez‐Sendon, Pedro L. Sanchez
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020-04-01
Seri Bilgileri:ESC Heart Failure
Konular:
Cancer
Cardio‐oncology
Cardiotoxicity
Heart failure
Sacubitril–valsartan
Online Erişim:https://doi.org/10.1002/ehf2.12627
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller